PDA

View Full Version : VRML - Vermillion Inc



aqecaen
10-26-2015,
About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology, hematology, cardiology and women's health with an initial focus in ovarian cancer. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

AlmoPa
10-27-2015,
Looks like an oversold bounce, and a good one too!

However, resistance is starting to hit, watching for a pull back soon.


Recent news

Vermillion Receives Award From the Society of Gynecologic Oncologists
Company to Present New Data on its Ovarian Cancer Diagnostics Program at the Society of Gynecologic Oncologists' 39th Annual Meeting On Women's Cancer

FREMONT, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a high-value molecular diagnostics company, has received the Society for Gynecologic Oncologists (SGO) Basic Science Poster Award for its abstract, 'Prospective independent validation of a marker panel for distinguishing benign from malignant pelvic masses.' The abstract, which demonstrated that the Company's Ovarian Tumor Triage Test correctly identified 84 percent of ovarian cancer cases compared to only 33 percent identified using standard diagnosis methods without the test, was presented at the SGO's 38th Annual Meeting on Women's Cancer last year in San Diego.

avidinuq
10-27-2015,
and this doesn't look good to me. This is the Title line of how the stock is listed in Scottrade

Vermillion Inc VRML(D*):NASDAQ *Financial Status Indicator is Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

as well as this...

Vermillion Receives NASDAQ Notice of Non-Compliance
Wednesday 02/27/2008 4:03 PM ET - PR Newswire

Vermillion, Inc. (Nasdaq: VRML) announced that on February 22, 2008 it received a letter from The NASDAQ Stock Market LLC that indicated the Company is not in compliance with Marketplace Rule 4310(c)(3), which requires it to have (i) a minimum of $2,500,000 in stockholders' equity; (ii) $35,000,000 in market value of listed securities; or (iii) $500,000 of net income from continuing operations for the most recently completed fiscal year or two of the three most recently completed fiscal years.

In accordance with Marketplace Rule 4310(c)(8)(C), the Company has been afforded 30 calendar days, or until March 24, 2008, to regain compliance. If, any time prior to March 24, 2008, the market value of listed securities of the Company's common stock is $35,000,000 or more for a minimum of 10 consecutive business days, NASDAQ may determine that the Company has regained compliance. If the Company does not regain compliance by March 24, 2008, NASDAQ will provide written notification that the Company's securities are subject to delisting. At that time, the Company may request a hearing before a NASDAQ Listing Qualifications Panel. The Company's securities would remain listed pending the issuance of a decision by the Panel.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology, hematology, cardiology and women's health with an initial focus in ovarian cancer. Vermillion is based in Fremont, California. Additional information about Vermillion can be found on the Web at http://www.vermillion.com.

SOURCE Vermillion, Inc.

http://www.vermillion.com

bczbivcy71
10-28-2015,
Breaking news, but too late to the dance.
Up 2000+% today.

http://www.rttnews.com/Content/Quick...=Quick%20Facts

Anthonyfamy
10-28-2015,
Quote:
Originally Posted by Richie Rich View Post
Up 2000+% today.

http://www.rttnews.com/Content/Quick...=Quick%20Facts
That's just friggin' crazy!